RECRUITING

A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

It is recommended that cancer centers screen patients for distress and refer them to mental health services when their distress levels reach a certain level. However, many cancer centers don't have distress screening and referral programs. This study will provide valuable information about one distress screening and referral program and whether it can be helpful for a large and diverse group of cancer patients that includes both English- and Spanish-speaking patients.

Official Title

A Pilot Distress Screening and Referral Program to Detect Comorbid Psychosocial Distress in NYC Safety Net Hospitals Serving Diverse and Underserved Patients Diagnosed With Cancer

Quick Facts

Study Start:2025-07-22
Study Completion:2026-07-22
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07117461

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * New solid tumor cancer diagnosis (per EMR)
  2. * Treated or will be treated at Jamaica Hospital Medical Center (per EMR)
  3. * Has a NCCN DT score of 0 through 10 (per EMR)
  4. * Age ≥ 18 years (per EMR or self-report)
  5. * English- or Spanish preferred language for healthcare (per self-report)
  6. * Able to provide consent (per completion of consent)
  1. * In the provider or investigative teams' judgement, cognitively not intact to participate in the study (per EMR or investigative team)

Contacts and Locations

Study Contact

Devika Jutagir, PhD
CONTACT
646-888-8361
jutagird@mskcc.org
Francesca Gany, MD
CONTACT
646-888-8054
ganyf@mskcc.org

Principal Investigator

Devika Jutagir, PhD
PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center

Study Locations (Sites)

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065
United States
Medisys Health Network (Data Collection Only)
Richmond Hill, New York, 11418
United States

Collaborators and Investigators

Sponsor: Memorial Sloan Kettering Cancer Center

  • Devika Jutagir, PhD, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-22
Study Completion Date2026-07-22

Study Record Updates

Study Start Date2025-07-22
Study Completion Date2026-07-22

Terms related to this study

Keywords Provided by Researchers

  • Solid Tumor Cancer
  • 24-296
  • Memorial Sloan Kettering Cancer Center

Additional Relevant MeSH Terms

  • Solid Tumor Cancer